Google Vs Microsoft: Google Seeks Court Order To Procure Documents From Microsoft To Defend DOJ Lawsuit

Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google sought a federal judge order on Microsoft Corp (NASDAQ:MSFT) to hand over internal documents from certain…
  • Alphabet Inc’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google sought a federal judge order on Microsoft Corp (NASDAQ:MSFT) to hand over internal documents from certain executives to defend a Justice Department’s monopoly lawsuit, Bloomberg reported.
  • Google served a subpoena to Microsoft over three months ago, seeking documents regarding Microsoft’s Bing search engine and its Internet Explorer and Edge as per a Reuters report.
  • Google alleged that Microsoft refused to search the files of 19 executives relevant to Google’s defense. Microsoft is a crucial player in the DOJ lawsuit, which alleged Google was abusing its internet search dominance. 
  • The government accused Google of illegally using its market clout to thwart competition from Microsoft’s Bing search engine. 
  • Google reasoned that some documents might clarify whether Microsoft restrained from competing with Google or failed to compete successfully.
  • Microsoft argued Google’s request for documents was unreasonable and burdensome. It reportedly offered to collect documents from 27 individuals. However, Google requested information for an additional 28, for a total of 55.
  • The companies recently ended an almost six-year treaty to prevent open warfare between the rival Big Tech companies.
  • Price action: GOOG shares traded lower by 1.03% at $2,702.81, and MSFT shares traded lower by 0.70% at $284.49 on the last check Friday.
  • Photo by Firmbee from Pixabay
Total
0
Shares
Related Posts
Read More

These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry

In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its success on the regulation and approval of scheduled psychoactive substances for mental health and other health indications.

ATAI